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Abstract
Inbreeding depression refers to lower fitness among offspring of genetic relatives (1). This reduced 
fitness is caused by the inheritance of two identical chromosomal segments (autozygosity) across 
the genome, which may expose the effects of (partially) recessive deleterious mutations. Even 
among outbred populations, autozygosity can occur to varying degrees due to cryptic relatedness 
between parents (2). Using dense genome-wide SNP data, we examined the degree to which 
autozygosity associated with measured cognitive ability in an unselected sample of 4,854 
participants of European ancestry. We used runs of homozygosity—multiple homozygous SNPs in 
a row— to estimate autozygous tracts across the genome. We found that increased levels of 
autozygosity predicted lower general cognitive ability, and estimate a drop of 0.6 standard 
deviations among the offspring of first cousins (p = 0.003 - 0.02 depending on the model). This 
effect came predominantly from long and rare autozygous tracts, which theory predicts as more 
likely to be deleterious than short and common tracts. Association mapping of autozygous tracts 
did not reveal any specific regions that were predictive beyond chance after correcting for multiple 
testing genome-wide. The observed effect size is consistent with studies of cognitive decline 
among offspring of known consanguineous relationships (3). These findings suggest a role for 
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multiple recessive or partially recessive alleles in general cognitive ability, and that alleles 
decreasing general cognitive ability have been selected against over evolutionary time.
INTRODUCTION
General cognitive ability, traditionally measured through IQ-type psychometric tests, is a 
composite measure of cognition across multiple domains (4-6). It reliably predicts many life 
outcomes, such as health, longevity, social mobility, and occupational success (7-10). 
Decades of behavioral genetic research on general cognitive ability have shown moderate to 
high heritability estimates across development (11, 12), (13, 14). Results from GWAS and 
mixed linear models estimating variance components from SNPs suggest that the genetic 
variation underlying general cognitive ability is highly polygenic and mostly additive in 
nature (15-17). Furthermore, family studies have shown that offspring of consanguineous 
marriages have lower cognitive performance than the general population, supporting a role 
for inbreeding depression on general cognitive ability (3, 18-22).
The hypothesized cause of inbreeding depression, directional dominance of alleles that 
affect fitness, is thought to occur because selection acts more efficiently on additive effects 
than on recessive effects, which tends to bias deleterious effects toward a recessive mode of 
action (23). Inbreeding increases the probability that recessive/partially recessive deleterious 
mutations are homozygous by increasing the proportion of the genome that is autozygous 
(stretches of two homologous chromosomes in the same individual that are identical by 
descent). It is important to recognize that traits influenced by inbreeding depression are not 
predicted to have high levels of non-additive genetic variation; if inbreeding depression 
occurs because of the effects of rare, partially recessive deleterious mutations, most of the 
genetic variation will be additive (24, 25). While highly inbred individuals are autozygous 
for a substantial proportion of their genome (e.g. first cousin inbreeding leads to 6.25% 
average autozygosity genome-wide), autozygosity still occurs in outbred populations, albeit 
at lower levels, due to shared distant common ancestors between mates of no known 
relationship. Using high-density SNP arrays, the existence of autozygosity arising from 
distant inbreeding can be inferred using runs of homozygosity (ROH)—multiple 
homozygous SNPs in a row (2, 26, 27). To the degree that ROHs accurately measure 
autozygosity, ROHs capture not only homozygosity at measured SNPs, but also 
homozygosity at rare, unmeasured variants that exist within ROHs (28, 29). Thus, 
inbreeding estimates based on SNP-by-SNP excess homozygosity (Fsnp) capture the effects 
of homozygosity at common variants, while inbreeding estimates based on the proportion of 
the genome in ROHs (Froh) capture the effects of homozygosity at both common and rare 
variants.
To date, a number of studies have examined the effect of Froh burden and individual ROH 
regions on case/control and quantitative phenotypes, with early studies showing mixed 
results (30), including a non-significant Froh-cognitive ability relationship among 
individuals of European ancestry (N=2329) (31). Given the low variation in Froh among 
outbred samples, it is likely that these studies were underpowered (29). Investigations with 
larger samples have been more successful, finding increased Froh burden associated with 
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schizophrenia (32), height (33), and personality (34). Here, we present an analysis of Froh 
on general cognitive ability for 4854 individuals of European ancestry from eight samples, 
including five samples from the COGENT consortium (35). Understanding the contribution 
of autozygosity to individual differences in general cognitive ability can help elucidate the 
genetic architecture underlying this important and highly polygenic trait.
MATERIALS AND METHODS
Genetic and Sample quality control
Quality control (QC) procedures focused on properties that would be appropriate across a 
range of genotyping platforms that differed in SNP density. The main goal—analyzing runs 
of homozygosity to infer autozygosity—differed from the usual goal of finding associations 
between individuals SNPs and a phenotype, and so the procedures adopted were more 
stringent than those typically used in genome-wide association studies. Moreover, because 
so many SNPs (70-75% depending on the sample) were removed due to linkage 
disequilibrium pruning during ROH detection (see below), we could afford to use more 
stringent QC procedures, because dropped SNPs were likely to be in strong linkage 
disequilibrium with other nearby SNPs that were retained.
Table 1 lists the specific genotyping platforms used, with an average LD-pruned SNP 
density of 229K SNPs (range: 174K – 277K). The specific QC procedures and numbers of 
individuals or SNPs dropped at each step can be found in Table S4. Most steps are self-
explanatory, so only those needing clarification are discussed. Individuals whose self-
reported sex was discrepant from their genotypic sex were dropped, as these individuals 
might represent sample mix-ups. Individuals who self-identified as non-European ancestry 
were dropped, as both homozygosity and phenotypic measures might differ between 
ethnicities or across different levels of genetic admixture. We also merged the genotype data 
with HapMap2 reference samples (36), and removed anyone clearly outside of the European 
ancestry cluster. Finally, we did not remove individuals with excess genome-wide 
homozygosity as such individuals are more likely to be inbred and therefore informative for 
investigating the current hypothesis.
Runs of Homozygosity (ROHs) calling procedures
ROH were called in PLINK using the --homozyg command (37), which has been found to 
outperform other programs in accurately identifying autozygous segments (38). The current 
analysis incorporated the ROH tuning parameters recommended in Howrigan et al. (38). In 
particular, each dataset was pruned for either moderate LD (removing any SNP with R2 > 
0.5 with other SNP in a 50 SNP window) or strong LD (removing any SNP with R2 > 0.9 
with other SNP in a 50 SNP window). For moderate LD-pruned SNPs, the minimum SNP 
length threshold was set to 35, 45, or 50 SNPs. For strong LD-pruned SNPs, the minimum 
SNP length threshold was set to 65 SNPs. We did not allow for heterozygote SNPs, used a 
window size equal to the minimum SNP threshold, and allowed for 5% of SNPs to be 
missing within the window (38). In addition, PLINK's --homozyg-group and --homozyg-
match commands were used to find allelically matching ROH that overlapped at least 95% 
of physical distance of the smaller ROH. We chose the 65 SNP minimum pruned for strong 
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LD, as this parameter setting has been used in previous analyses (32). Primary Froh burden 
results, however, were similar for all four tuning parameters used (Table S1).
Froh genotype
Genome-wide ROH burden, or Froh, represents the percent of the autosome in ROHs. Froh 
was derived by summing the total length of autosomal ROHs in an individual and dividing 
this by the total SNP-mappable autosomal distance (2.77 × 109). The distribution of Froh in 
the sample is listed in Figure S1. Froh can be affected by population stratification (e.g., if 
background levels of homozygosity or autozygosity differ across ethnicities), low quality 
DNA leading to bad SNP calls, and heterozygosity levels that differ depending on, for 
example, genotype plate, DNA sources, SNP calling algorithm, or sample collection site. We 
controlled for covariates in two steps – within dataset and across the combined datasets. 
Within each dataset, we controlled for the first ten principal components generated from an 
identity-by-state matrix derived from a subset of SNPs (~50,000) within each dataset. We 
also controlled for age and age-squared within dataset when provided, as age information 
was not available in four of the eleven studies (Table 2). We used the linear model residuals 
from within each dataset as our Froh genotype moving forward. Across the combined 
samples, we controlled for gender, dataset, the percentage of missing calls - which has been 
shown to track the quality of SNP calls (39), and excess SNP-by-SNP homozygosity (Fsnp, 
from PLINK's --het command) - which can be used to test the effects of homozygosity at 
common but not rare variants.
General cognitive ability phenotype
Table 2 lists the sample characteristics and various measures of general cognitive ability 
employed (additional description in Supplementary information). Measures of general 
cognitive ability were standardized within each dataset (Figure S2). We controlled for 
potential confounds in same manner as the Froh genotype, regressing out the first ten 
principal components, age, and age-squared within each dataset, and dataset, gender, SNP 
missingness, and Fsnp across the combined dataset.
Froh burden analysis
To test the effect of Froh burden on general cognitive ability, we examined both fixed-effects 
modeling (i.e. lm() in R) and mixed-effects modeling treating dataset as a random effect (i.e. 
lmer() from the lme4 package in R). Both analyses showed very consistent results, and we 
used fixed-effects modeling approach for all analyses hereafter. For our primary analysis, we 
tested the effects of Froh after controlling for Fsnp as we have done previously (32), not 
only because this analysis provides information on the importance of rare recessive variants 
in particular, which are thought to be the primary cause of inbreeding depression (23), but 
also because controlling for Fsnp can increase power to detect Froh relationships in the 
presence of genotyping errors (29). We also report the effects of Froh not controlling for 
Fsnp. In follow up analyses, Froh burden was partitioned into short and long ROH as well as 
common and uncommon ROH according to median splits of both variables. Due to the 
variation in SNP density across dataset platforms (ranging from 300k to over 1 million 
SNPs), median splits for both length and frequency were calculated within each dataset (see 
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Table S2). Across all datasets, 34% of the total length of ROHs was composed of short 
ROHs and 66% was composed of long ROHs, whereas 38% of the total ROH length was 
composed of common and 62% was composed of uncommon ROHs.
ROH mapping analysis
To investigate whether specific genomic regions predicted general cognitive ability, we co-
opted the rare CNV commands used in PLINK, whereby each ROH segment was tested at 
the two SNPs defining the start and end position. At each position, all individuals with ROH 
overlapping the tested SNP were included as ROH carriers. General cognitive ability 
residuals, after controlling for all covariates, were used as the dependent variable. We 
restricted ROH mapping to positions where five or more ROHs existed across the sample, 
and derived statistical significance at each position from one million permutations in 
PLINK.
To derive a genome-wide significance threshold for multiple testing, we estimated the 
family-wise error rate directly from permutation. To do so, we ran 1000 permutations on the 
general cognitive ability phenotype and obtained empirical p-values in the same manner as 
above. We then extracted the most significant p-value from each permutation, and used the 
95th percentile (or 50th most significant p-value among the set) as our genome-wide 
significance threshold (p = 4e−6). Thus, under the null hypothesis, we had a 5% chance of 
observing a single genome-wide significant hit.
RESULTS
Figure 1 shows the parameter estimates of Froh predicting general cognitive ability within 
each dataset and combined across the full sample. In the combined sample, higher levels of 
Froh were associated, albeit modestly, with lower general cognitive ability (β = −9.8, t(4852) 
= −2.31, p = 0.02). This estimate suggests that every one percentage point increase in Froh 
corresponds to a ~0.1 standard deviation reduction in general cognitive ability, extrapolating 
to an expected ~0.6 standard deviation reduction among the offspring of first cousins. Our 
estimate was not driven by potential outliers in Froh, as it increased when we removed the 
33 individuals with no ROH calls and 5 individuals with > 6% Froh (β = −12.8, t(4814) = 
−2.68, p = 0.007), and was insensitive to ROH calling thresholds ≥ 50 consecutive 
homozygous SNPs (Figure S3). The relationship between Froh and general cognitive ability 
remained stable across models where covariates were removed in step-wise fashion or split 
by age groups or sex. In particular, the estimate for Froh on general cognitive ability was 
more significant when SNP-by-SNP homozygosity, Fsnp, was removed as a covariate (β = 
−9.9, t(4852) = −2.92, p = 0.003), whereas Fsnp did not itself predict general cognitive 
ability (β = −0.1, t(4852) = −0.04, p = 0.97), and suggests that homozygosity at rare variants 
drove the observed Froh effect. Finally, contrary to a previous report (31), we found no 
evidence for increased assortative mating or inbreeding at the upper tail of the cognitive 
ability distribution.
Additional analyses found that Froh from long ROH (β = −9.2, t(4852) = −2.15, p = 0.03), 
and rare ROH (β = −15.4, t(4852) = −2.56, p = 0.01) remain significant, whereas Froh 
estimates from short or common ROH did not (p > 0.30 for both, see Supplementary 
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Information for full analysis). Both short autozygous haplotypes, which arise from more 
distant common ancestry, and common autozygous haplotypes, which arise from chance 
pairing of common haplotypes segregating in the population, have had more opportunities to 
be subject to natural selection when autozygous. This may bias them to be less deleterious 
when autozygous than long or rare haplotypes.
In addition to Froh burden, we mapped individual ROH along the autosome to assess 
whether specific regions associate with general cognitive ability. Using PLINK, we mapped 
and analyzed ROH segments at their respective ends (i.e. the first and last SNP in the ROH), 
counting all overlapping ROH incorporating that SNP as ROH carriers. We observed 
minimal test statistic inflation across the genome (λGC = 1.02; QQ plot shown in Figure S5), 
suggesting that the integration of various sub-populations within the full sample were 
adequately controlled and did not inflate ROH mapping test statistics. Although we did not 
identify any specific ROH regions that surpassed strict genome-wide correction (Figure 2), 
we highlight sixteen regions with p < 0.001 as potential areas of interest (Table S3). Our top 
association, located on chromosome 21q21.1 (p = 5.4e−5, Figure S6), predicts lower general 
cognitive ability and has a distinct peak over USP25, a ubiquitin specific peptidase gene 
expressed across a variety tissues types, including brain (40).
DISCUSSION
After stringent quality control and the application of preferred methods for detecting 
autozygosity, we observe a significant, albeit modest, trend of autozygosity burden (Froh) 
lowering cognitive ability among outbred populations of European ancestry. Inbreeding 
among first cousins leads to an average Froh burden of 6.25%, and corresponds to a 
predicted drop of 9.19 IQ points in the current study, an effect consistent with previously 
detected effects from pedigree-based consanguineous inbreeding (3). In addition, we find 
that long and rare ROH are driving Froh association to general cognitive ability, as the 
relationship of Froh to general cognitive ability disappear when restricting to either short or 
common ROH, but remain when considering either long or rare ROH. At the level of 
individual ROH, however, we do not identify any specific autozygous loci that significantly 
predicted general cognitive ability after genome-wide correction.
There were several limitations to the current study that were largely a consequence of 
combining multiple datasets together. First, the operational construct of general cognitive 
ability differed somewhat between datasets (see Table 2 and Supplementary Information), 
and statistical power can be lost as a function of the degree of phenotypic heterogeneity in 
measured cognitive ability across samples. Second, the autozygosity – cognitive ability 
relationship might be mediated differentially across sites/datasets. For example, analysis of 
the Netherlands Twin Registry found that increased religiosity was associated with both 
higher autozygosity and lower rates of major depression in the Netherlands, which if 
unaccounted for, would have obscured the true relationship between major depression and 
autozygosity (41). More recent evidence in the same dataset found that increased parental 
migration mediated the relationship of education attainment to autozygosity (42). 
Unfortunately, these potential confounds are often unmeasured and were unavailable in the 
current study. Third, despite following strict QC procedures, the use of different genotyping 
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platforms affects ROH calls across datasets. Although dataset was included as a covariate, 
such differences add noise and reduce statistical power, and it is impossible to rule out all 
biases that could arise from such differences between datasets. Finally, we did not measure 
copy number deletions in our dataset, and hemizygosity due to deletions could be included 
in the Froh estimates. Previous studies, however, using deletions called from intensity data 
found that fewer than 0.3% of the total lengths of ROHs in their samples were actually 
hemizygous, suggesting that deletions had a minimal effect on the present results (2, 32).
Autozygosity is the most direct measure of inbreeding at the genetic level. It can help 
elucidate the genetic architecture underlying heritable traits like general cognitive ability and 
provide clues to the evolutionary forces that acted on alleles affecting the trait. Our results 
suggest that alleles that decrease cognitive ability are more recessive than otherwise 
expected, and are consistent with the hypothesis that alleles that lead to lower cognitive 
ability have, on average, been under negative selection ancestrally.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
ACKNOWLEDGEMENTS
We would like to acknowledge Bruce Walsh, Robin Corley, Ken Krauter, and Brian Browning for their helpful 
comments and suggestions in the preparation of this manuscript.
Funding sources
This work has been supported by grants from the National Institutes of Health:
R01 MH079800 and P50 MH080173 to Anil K Malhotra
RC2 MH089964 to Todd Lencz
R01 MH080912 to David C Glahn
K23 MH077807 to Katherine E Burdick
K01 MH085812 and R01 MH100141 to Matthew C Keller
LOGOS
The LOGOS study was supported by the University of Crete Research Funds Account (E.L.K.E.1348)
TOP
The TOP Study Group was supported by the Research Council of Norway grants 213837 and 223273, South-East 
Norway Health Authority grants 2013-123, and K.G. Jebsen Foundation.
NCNG
The NCNG study was supported by Research Council of Norway grants 154313/V50 and 177458/V50. The NCNG 
GWAS was financed by grants from the Bergen Research Foundation, the University of Bergen, the Research 
Council of Norway (FUGE, Psykisk Helse), Helse Vest RHF and Dr Einar Martens Fund.
Howrigan et al. Page 8
Mol Psychiatry. Author manuscript; available in PMC 2016 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Bibliography
1. Charlesworth D, Willis JH. The genetics of inbreeding depression. Nature reviews Genetics. 2009; 
10(11):783–96.
2. McQuillan R, Leutenegger A- L, Abdel-Rahman R, Franklin CS, Pericic M, Barac-Lauc L, et al. 
Runs of Homozygosity in European Populations. The American Journal of Human Genetics. 2008; 
83:359–72. [PubMed: 18760389] 
3. Afzal M. Consequences of Consanguinity on Cognitive Behavior. Behavioral Genetics. 1988; 18(5):
12.
4. Carroll, JB. Human cognitive abilities: A survey of factor-analytic studies. Cambridge University 
Press; New York, NY: 1993. 
5. Johnson W, Bouchard TJ, Krueger RF, McGue M, Gottesman II. Just one g: consistent results from 
three test batteries. Intelligence. 2004; 32(1):95–107.
6. Johnson W, Nijenhuis Jt, Bouchard TJ. Still just 1 g: Consistent results from five test batteries. 
Intelligence. 2008; 36(1):81–95.
7. Batty GD, Deary IJ, Gottfredson LS. Premorbid (early life) IQ and later mortality risk: Systematic 
review. Annals of Epidemiology. 2007; 17(4):11.
8. Deary IJ, Weiss A, Batty GD. Intelligence and personality as predictors of illness and death: How 
researchers in differential psychology and chronic disease epidemiology are collaborating to 
understand and address health inequalities. Psychological Science in the Public Interest. 2010; 
11:53–79. [PubMed: 26168413] 
9. Gottfredson LS, Deary IJ. Intelligence Predicts Health and Longevity, but Why? Current Directions 
in Psychological Science. 2004; 13(1):1–4.
10. Strenze T. Intelligence and socio-economic success: a meta-analytic view of longitudinal research. 
Intelligence. 2007; 35:401–26.
11. Erlenmeyer-Kimling L, Jarvik LF. Genetics and Intelligence: A Review. Science. 1963; 142(3598):
3.
12. Bouchard TJ, McGue M. Familial Studies of Intelligence: A Review. Science. 1981; 212:5.
13. Deary IJ, Johnson W, Houlihan LM. Genetic foundations of human intelligence. Human Genetics. 
2009; 126:18.
14. Deary IJ, Yang J, Davies G, Harris SE, Tenesa A, Liewald D, et al. Genetic contributions to 
stability and change in intelligence from childhood to old age. Nature. 2012; 482(7384):212–5. 
[PubMed: 22258510] 
15. Benyamin B, Pourcain BS, Davis OS, Davies G, Hansell NK, Brion M- JA, et al. Childhood 
intelligence is heritable, highly polygenic and associated with FNBP1L. Molecular Psychiatry. 
2014; 19:6. [PubMed: 24362540] 
16. Davies G, Tenesa A, Payton A, Yang J, Harris SE, Liewald D, et al. Genome-wide association 
studies establish that human intelligence is highly heritable and polygenic. Molecular Psychiatry. 
2011:11.
17. Marioni RE, Davies G, Hayward C, Liewald D, Kerr SM, Campbell A, et al. Molecular genetic 
contributions to socioeconomic status and intelligence. Intelligence. 2014; 44:7.
18. Agrawal N, Sinha SN, Jensen AR. Effects of Inbreeding on Raven Matrices. Behavior Genetics. 
1984; 14(6):7.
19. Badaruddoza, Afzal M. Inbreeding depression and intelligence quotient among north Indian 
children. Behavior Genetics. 1993; 23(4):343–7. [PubMed: 8240214] 
20. Bashi J. Effects of inbreeding on cognitive performance. Nature. 1977; 266:3.
21. Morton NE. Effect of inbreeding on IQ and mental retardation. Proceedings of the National 
Academy of Science. 1978; 75(8):3906–8.
22. Woodley MA. Inbreeding depression and IQ in a study of 72 countries. Intelligence. 2009; 37:268–
76.
23. Charlesworth D, Willis JH. The genetics of inbreeding depression. Nature Reviews Genetics. 2009; 
10:8.
Howrigan et al. Page 9
Mol Psychiatry. Author manuscript; available in PMC 2016 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
24. Mukai T, Cardellino RA, Watanabe TK, Crow JF. The genetic variance for viability and its 
components in a local population of Drosophila melanogaster. Genetics. 1974; 78(4):1195–208. 
[PubMed: 4218182] 
25. Houle D, Hoffmaster DK, Assimacopoulos S, Charlesworth B. The genomic mutation rate for 
fitness in Drosophila. Nature. 1992; 359(6390):58–60. [PubMed: 1522887] 
26. Nothnagel M, Lu TT, Kayser M, Krawczak M. Genomic and geographic distribution of SNP-
defined runs of homozygosity in Europeans. Human molecular genetics. 2010; 19(15):2927–35. 
[PubMed: 20462934] 
27. Kirin M, McQuillan R, Franklin CS, Campbell H, McKeigue PM, Wilson JF. Genomic Runs of 
Homozygosity Record Population History and Consanguinity. PloS one. 2010; 5(11):e13996. 
[PubMed: 21085596] 
28. Carothers AD, Rudan I, Kolcic I, Polasek O, Hayward C, Wright AF, et al. Estimating Human 
Inbreeding Coefficients: Comparison of Genealogical and Marker Heterozygosity Approaches. 
Annals of Human Genetics. 2006; 70:11.
29. Keller MC, Visscher PM, Goddard ME. Quantification of Inbreeding Due to Distant Ancestors and 
Its Detection Using Dense Single Nucleotide Polymorphism Data. Genetics. 2011; 189:13.
30. Ku CS, Naidoo N, Teo SM, Pawitan Y. Regions of homozygosity and their impact on complex 
diseases and traits. Human Genetics. 2011; 129:15.
31. Power RA, Nagoshi C, DeFries JC, Consortium WTCC. Plomin R. Genome-wide estimates of 
inbreeding in unrelated individuals and their association with cognitive ability. European Journal 
of Human Genetics. 2014; 22:386–90. [PubMed: 23860046] 
32. Keller MC, Simonson MA, Ripke S, Neale BM, Gejman PV, Howrigan DP, et al. Runs of 
Homozygosity Implicate Autozygosity as a Schizophrenia Risk Factor. PLoS genetics. 2012; 
8(4):e1002656. [PubMed: 22511889] 
33. McQuillan R, Eklund N, Pirastu N, Kuningas M, McEvoy BP, Esko T, et al. Evidence of 
inbreeding depression on human height. PLoS genetics. 2012; 8(7):e1002655. [PubMed: 
22829771] 
34. Verweij KJH, Yang J, Lahti J, Veijola J, Hintsanen M, Pulkki-Raback L, et al. Maintenance of 
genetic variation in human personality: testing evolutionary models by estimating heritability due 
to common causal variants and investigating the effect of distant inbreeding. Evolution; 
international journal of organic evolution. 2012; 66(10):3238–51.
35. Lencz T, Knowles E, Davies G, Guha S, Liewald DC, Starr JM, et al. Molecular genetic evidence 
for overlap between general cognitive ability and risk for schizophrenia: a report from the 
Cognitive Genomics consorTium (COGENT). Molecular psychiatry. 2014; 19(2):168–74. 
[PubMed: 24342994] 
36. International HapMap C, Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. A second 
generation human haplotype map of over 3.1 million SNPs. Nature. 2007; 449(7164):851–61. 
[PubMed: 17943122] 
37. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for 
whole-genome association and population-based linkage analyses. American journal of human 
genetics. 2007; 81(3):559–75. [PubMed: 17701901] 
38. Howrigan DP, Simonson MA, Keller MC. Detecting autozygosity through runs of homozygosity: a 
comparison of three autozygosity detection algorithms. BMC genomics. 2011; 12:460. [PubMed: 
21943305] 
39. Laurie CC, Doheny KF, Mirel DB, Pugh EW, Bierut LJ, Bhangale T, et al. Quality Control and 
Quality Assurance in Genotypic Data for Genome-Wide Association Studies. Genetic 
Epidemiology. 2010; 34:12.
40. Valero R, Marfany G, Gonzalez-Angulo O, Gonzalez-Gonzalez G, Puelles L, Gonzalez-Duarte R. 
USP25, a Novel Gene Encoding a Deubiqiutinating Enzyme, is Located in the Gene-Poor Region 
of 21q11.2. Genomics. 1999; 62:395–405. [PubMed: 10644437] 
41. Abdellaoui A, Hottenga J- J, Xiao X, Scheet P, Ehli EA, Davies GE, et al. Association Between 
Autozygosity and Major Depression: Stratification Due to Religious Assortment. Behavioral 
Genetics. 2013; 43:13.
Howrigan et al. Page 10
Mol Psychiatry. Author manuscript; available in PMC 2016 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
42. Abdellaoui A, Hottenga J- J, Willemsen G, Bartels M, Beijsterveldt Tv, Ehli EA, et al. Educational 
attainment influences genetic variation through migration and assortative mating. 2014
Howrigan et al. Page 11
Mol Psychiatry. Author manuscript; available in PMC 2016 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Forest plot of slope estimates and 95% confidence intervals of Froh predicting general 
cognitive ability
Points represent slope estimates and bars represent 95% confidence intervals. Datasets are 
color coded by the genotyping platform used. The three GAIN datasets were combined for 
clarity.
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Figure 2. ROH mapping manhattan plot predicting general cognitive ability
Top panel: −log10 p-values for ROH breakpoint regions predicting general cognitive ability. 
Regions with p-values below 0.001 are flagged for predicting lower cognitive ability (red) 
and higher cognitive ability (blue). The red dotted line is the genome-wide correction 
estimate, set at 4e−6, which is the top 5% of minimum p-values observed across 1000 
permutations. Bottom panel: ROH frequencies for each region across the autosome, with 
the highest frequency of ROH due to balancing selection in the MHC (chr6) and recent 
positive selection in lactase persistence gene region (chr2).
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